Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2010-024028-24Phase 3Active
Phase 3 trial of pentoxifylline in irritable bowel syndrome (IBS), sponsored by Hospital Universitario de Canarias. Primary endpoint: Clinical evolution and severity of IBS. Started Jan 2012; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2010-024028-24.